Doximity (DOCS) Stock Price, News & Analysis

Company Overview

Doximity, Inc. operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.

The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.

Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products. Its platform is primarily focused on the United States healthcare market.

Founded in 2010, Doximity was co-founded by Jeff Tangney, Nate Gross and Shari Buck. Jeff Tangney serves as the company's chief executive officer, and Doximity became publicly traded on the New York Stock Exchange under the symbol DOCS in 2021.

Key Stats

• Today's Range: $30.20 to $30.92
• 50-Day Range: $20.63 to $30.38
• 52-Week Range: $17.15 to $71.37
• Volume: 137,182 shs
• Average Volume: 3.99 million shs
• Market Capitalization: $5.42 billion
• P/E Ratio: 35.76
• Dividend Yield: N/A
• Price Target: $31.95
• Consensus Rating: Hold

Doximity Stock Analysis - MarketRank™

Doximity scored higher than 77% of companies evaluated by MarketBeat, and ranked 147th out of 882 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Hold

Consensus Rating

Doximity has received a consensus rating of Hold. The company's average rating score is 2.24, and is based on 1 strong buy rating, 7 buy ratings, 14 hold ratings, and 3 sell ratings.

Upside/Downside

The consensus price target for Doximity is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Doximity has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 28.38%

Earnings Growth

Earnings for Doximity are expected to grow by 28.38% in the coming year, from $0.74 to $0.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Doximity is 35.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.05.

Price to Earnings Ratio vs. Sector

The P/E ratio of Doximity is 35.74, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.59.

Price to Earnings Growth Ratio

Doximity has a PEG Ratio of 23.86. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Doximity has a P/B Ratio of 5.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.28% of the float of Doximity has been sold short.

Short Interest Ratio / Days to Cover

Doximity has a short interest ratio ("days to cover") of 3.55, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Doximity has recently decreased by 8.87%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Doximity does not currently pay a dividend.

Dividend Growth

Doximity does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.18

News Sentiment

Doximity has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 27 news articles for Doximity this week, compared to 8 articles on an average week.

Search Interest

Only 7 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.

MarketBeat Follows

2 people have added Doximity to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $533,688.00 in company stock.

Percentage Held by Insiders

31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/12/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:DOCS
• Previous Symbol: NASDAQ:DOCS
• CIK: 1516513
• Web: doximity.com
• Phone: (650) 549-4330
• Fax: N/A
• Employees: 880
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Doximity: $31.95
• High Price Target: $65.00
• Low Price Target: $18.00
• Potential Upside/Downside: +3.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.24
• Research Coverage: 25 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.85
• Trailing P/E Ratio: 36.30
• Forward P/E Ratio: 41.68
• P/E Growth: 23.86
• Net Income: $196.05 million
• Net Margins: 25.48%
• Pretax Margin: 34.51%
• Return on Equity: 18.06%
• Return on Assets: 15.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.08
• Quick Ratio: 6.08

Sales & Book Value

• Annual Sales: $644.86 million
• Price / Sales: 8.53
• Cash Flow: $1.25 per share
• Price / Cash Flow: 24.61
• Book Value: $5.19 per share
• Price / Book: 5.94

Miscellaneous

• Outstanding Shares: 178,250,000
• Free Float: 121,564,000
• Market Cap: $5.50 billion
• Optionable: N/A
• Beta: 1.22